Does Medicaid Cover Spravato in Ohio? (2026)

If you’ve been through multiple antidepressants without relief, you’ve probably asked your provider about Spravato (esketamine) and immediately wondered about the cost. The short answer is yes, Ohio Medicaid does cover Spravato, but only when specific clinical criteria are met and a prior authorization is approved first. EverHope Wellness Center in Delaware, Ohio accepts CareSource Medicaid, so this is a question we help patients navigate every week.

The specifics matter just as much as the answer itself: which plan you’re on, what “treatment-resistant” actually means, and what your provider needs to document all affect how smoothly your approval goes.

Why Prior Authorization Matters

Spravato is a nasal spray form of esketamine, and it’s only FDA-approved for two specific uses: treatment-resistant depression (TRD) in adults, and major depressive disorder with acute suicidal ideation or behavior. Because it’s a specialty medication administered under medical supervision, every Ohio Medicaid managed care plan requires prior authorization before it will pay for treatment. That means your prescriber has to submit documentation proving you meet the criteria before your first dose is covered.

How CareSource Decides Who Qualifies

CareSource is the largest Medicaid plan in Ohio, and its published pharmacy policy lays out exactly what has to be documented for Spravato to be approved. The criteria differ depending on which diagnosis applies.

For major depressive disorder with suicidal ideation, the policy requires that the member be at least 18, that a psychiatrist at a REMS-certified center is prescribing it, that the suicidal ideation or behavior is documented as requiring immediate intervention, and that Spravato is used alongside an oral antidepressant. If approved, coverage is granted for one month at a time.

For treatment-resistant depression, the bar is different. The member must have already tried and failed at least two oral antidepressants from different drug classes, each at an optimized dose for at least eight weeks, with at least one being an SSRI or SNRI. The prescriber also has to document a baseline depression score using a recognized scale like the PHQ-9 or MADRS. If all of that is met, the first approval covers two months, and reauthorization (which requires documented improvement on a rating scale) can extend coverage for another six.

This information comes directly from CareSource’s Ohio Medicaid pharmacy policy for Spravato, last revised in early 2025. One detail worth noting: the requirement to combine Spravato with an oral antidepressant for TRD was removed in that update, meaning it can now be approved as a standalone treatment for treatment-resistant depression, matching the current FDA label.

What Counts as “Treatment-Resistant” Depression?

This term comes up constantly in coverage conversations, so it’s worth explaining plainly. Under CareSource’s policy, treatment-resistant depression means you’ve tried at least two different oral antidepressants, from two different drug classes, each at a full and appropriate dose, for at least eight weeks each, without adequate improvement. At least one of those medications has to be an SSRI (like sertraline or fluoxetine) or an SNRI (like duloxetine or venlafaxine). If you switched medications after only two or three weeks, or never got up to a therapeutic dose, that attempt typically won’t count toward meeting the criteria. This is why a detailed medication history matters so much when your provider is building the case for approval.

What About Other Ohio Medicaid Plans?

CareSource isn’t the only managed care option in Ohio. The state currently contracts with seven managed care organizations for general Medicaid:

• Anthem Blue Cross and Blue Shield
• AmeriHealth Caritas Ohio
• Buckeye Health Plan
• CareSource
• Humana Healthy Horizons
• Molina Healthcare of Ohio
• UnitedHealthcare Community Plan

Each plan sets its own pharmacy policy, but because Spravato is a REMS-restricted specialty drug, prior authorization is standard across all of them. The specific documentation requirements can vary slightly by plan, which is one reason it helps to work with a clinic that’s already familiar with the process.

Why the REMS Requirement Matters for Coverage

Every prior authorization criteria you’ll find, whether from CareSource or any other Ohio Medicaid plan, includes one non-negotiable line: the prescriber must be a psychiatrist working out of a REMS-certified center. REMS stands for Risk Evaluation and Mitigation Strategy, a safety program the FDA requires because Spravato can cause sedation, dissociation, and short-term increases in blood pressure. As part of that program, certified clinics are required to:

• Dispense and administer Spravato only on-site, never for home use
• Monitor patients for at least two hours after each dose
• Track blood pressure and other vital signs throughout the visit
• Confirm a safe ride home before discharging the patient

If a request comes from a provider or location that isn’t REMS-certified, Medicaid won’t approve it, regardless of how well the clinical criteria are otherwise documented. This is one of the first things worth confirming with any clinic you’re considering.

What This Looks Like in Practice

Meeting the criteria on paper is only half the equation. Your prescriber needs to gather your treatment history, confirm which medications you’ve tried and for how long, and complete a standardized depression assessment before submitting the authorization request. Missing documentation is the most common reason a request gets delayed or denied, not the medication itself.

At EverHope, our team handles this process directly. We review your prior treatment history during your evaluation, complete the required rating scales, and submit the prior authorization on your behalf, so you’re not stuck making phone calls to your insurance company while trying to manage depression symptoms. If your case doesn’t meet criteria the first time, we’ll walk you through what needs to change and help you get there.

See How Spravato Works

What to Expect Cost-Wise if You’re Approved

Once prior authorization is approved, CareSource and the other Ohio Medicaid plans cover both the medication and the required in-clinic monitoring, since Spravato can only be administered and observed at a certified treatment center. Members typically have little to no out-of-pocket cost for the medication itself under Medicaid, though it’s worth confirming your specific plan’s cost-sharing rules, since Medicaid managed care plans occasionally differ on copays for office visits tied to the treatment.

If you’re weighing whether the treatment itself is worth pursuing, our post on the benefits of Spravato for treatment-resistant depression walks through what patients typically experience. And if side effects are your main hesitation, we’ve also broken down what’s normal and what’s not with Spravato side effects.

Common Questions About Medicaid and Spravato

Does Medicaid cover the required monitoring appointments?

Yes. Because Spravato requires in-clinic administration and at least two hours of observation afterward, those visits are billed as part of the covered treatment, not as separate, unreimbursed appointments.

What if I’m on MyCare Ohio instead of standard Medicaid?

If you’re dually eligible for Medicare and Medicaid and enrolled in MyCare Ohio, coverage still requires prior authorization, but the request may route through your MyCare plan’s combined Medicare/Medicaid review process rather than a standalone Medicaid pharmacy policy. Your clinic can confirm which process applies to you.

Can my request be denied?

Yes, most commonly when documentation is incomplete, such as missing dates or doses for prior medications, or no baseline depression rating scale on file. A denial isn’t necessarily final. Your provider can usually appeal or resubmit once the missing information is added.

Do I need a referral from my primary care doctor?

Not typically. Spravato has to be prescribed by a psychiatrist at a REMS-certified center, so most patients come to us directly or through a referral from a therapist or primary care provider who suspects standard antidepressants aren’t working.

Steps to Take If You Think You Qualify

If you suspect you meet the criteria for treatment-resistant depression or you’re dealing with a depressive episode involving suicidal thoughts, the fastest path forward is a psychiatric evaluation that documents your history clearly. Bring a list of every antidepressant you’ve tried, the approximate dates and doses, and any reason a medication was stopped (side effects, lack of effectiveness, etc.). That information is exactly what a Medicaid reviewer needs to see to approve the request the first time.

See If You Qualify for Spravato with Everhope Wellness Center

Ohio Medicaid, including CareSource, does cover Spravato for adults who meet the FDA-approved criteria for treatment-resistant depression or MDD with acute suicidal ideation, but prior authorization is required in every case. The process is manageable when your treatment history is well documented and your prescribing clinic knows how to navigate it. If you’re in the Delaware, Ohio area and want to find out whether you qualify, our team at Everhope Wellness Center can walk you through your options.

Schedule Your Evaluation